CD6 and colorectal carcinoma: A recent study led by He et al. has shown that CD6-augmented CAR-T cells exhibited potent cytotoxicity targeting colorectal cancer (CRC) stem cells, making this targeted therapy a promising approach for CRC therapy [96].